Viracta Therapeutics, Inc.

VIRX · OTC
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Activities
Net Income-$51-$49-$115-$19
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$8$14$6$0
Change in WC$5$1$2$3
Other Non-Cash-$2-$1$88$0
Operating Cash Flow-$40-$35-$19-$16
Investing Activities
PP&E Inv.-$0-$0-$4-$0
Net Acquisitions$0$0$17$0
Inv. Purchases-$67-$71$0-$1
Inv. Sales/Matur.$82$17$0$17
Other Inv. Act.$0$0$13-$16
Investing Cash Flow$15-$54$13-$0
Financing Activities
Debt Repay.$0$20-$0$5
Stock Issued$0$2$62$1
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$78
Financing Cash Flow$0$23$62$45
Forex Effect$0$0$0$0
Net Chg. in Cash-$24-$67$56$29
Supplemental Information
Beg. Cash$37$104$47$18
End Cash$12$37$104$47
Free Cash Flow-$40-$36-$23-$16
Viracta Therapeutics, Inc. (VIRX) Financial Statements & Key Stats | AlphaPilot